QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic DiseasesZacks Investment Research • 08/30/24
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseasesGlobeNewsWire • 08/28/24
Unlocking Qiagen (QGEN) International Revenues: Trends, Surprises, and ProspectsZacks Investment Research • 08/05/24
Compared to Estimates, Qiagen (QGEN) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/01/24
Qiagen (QGEN) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 07/24/24
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in childrenGlobeNewsWire • 06/27/24
QIAGEN's software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labsGlobeNewsWire • 06/13/24
QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growthGlobeNewsWire • 06/12/24
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillanceGlobeNewsWire • 06/11/24
QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition periodGlobeNewsWire • 06/06/24